- Home
- DFH vs ARWR Comparison
DFH vs ARWR Comparison
Compare DFH & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFH
- ARWR
- Stock Information
- Founded
- DFH 2008
- ARWR 2003
- Country
- DFH United States
- ARWR United States
- Employees
- DFH N/A
- ARWR N/A
- Industry
- DFH Homebuilding
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- DFH Consumer Discretionary
- ARWR Health Care
- Exchange
- DFH Nasdaq
- ARWR Nasdaq
- Market Cap
- DFH 3.1B
- ARWR 2.5B
- IPO Year
- DFH 2021
- ARWR 1993
- Fundamental
- Price
- DFH $28.30
- ARWR $18.57
- Analyst Decision
- DFH Hold
- ARWR Buy
- Analyst Count
- DFH 1
- ARWR 11
- Target Price
- DFH $38.00
- ARWR $45.33
- AVG Volume (30 Days)
- DFH 438.5K
- ARWR 997.3K
- Earning Date
- DFH 10-31-2024
- ARWR 11-26-2024
- Dividend Yield
- DFH N/A
- ARWR N/A
- EPS Growth
- DFH 15.80
- ARWR N/A
- EPS
- DFH 3.03
- ARWR N/A
- Revenue
- DFH $4,028,851,000.00
- ARWR $19,648,000.00
- Revenue This Year
- DFH $15.83
- ARWR N/A
- Revenue Next Year
- DFH N/A
- ARWR $100.95
- P/E Ratio
- DFH $9.29
- ARWR N/A
- Revenue Growth
- DFH 8.59
- ARWR N/A
- 52 Week Low
- DFH $23.46
- ARWR $17.05
- 52 Week High
- DFH $44.38
- ARWR $39.83
- Technical
- Relative Strength Index (RSI)
- DFH 34.60
- ARWR 35.87
- Support Level
- DFH $30.55
- ARWR $21.20
- Resistance Level
- DFH $33.26
- ARWR $22.03
- Average True Range (ATR)
- DFH 1.54
- ARWR 0.87
- MACD
- DFH -0.30
- ARWR -0.04
- Stochastic Oscillator
- DFH 5.97
- ARWR 0.76
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. It designs, builds, and sells homes in Jacksonville, Orlando, Denver, the Washington D.C. metropolitan area, and Austin. The company operates through six geographical divisions namely, Jacksonville, Orlando, Denver, Washington DC (Capital), and the Carolinas (H&H Homes), Jet Home Loans LLC. Jacksonville division generates majority of the revenue for the firm.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.